Radiochromatography Systems Assist Cancer Antibody Trials

Chromatography

Radiochromatography Systems Assist Cancer Antibody Trials

08 Feb, 2011

Published over 15 years ago. See the latest and most current information on Chromatography.

The Cancer Sciences Division of Southampton University School of Medicine is using radio HPLC and radio TLC systems from LabLogic in the development and quality control of radio labelled antibody conjugates undergoing clinical trials for treating haematological malignancies.

The HPLC system incorporates an Agilent quaternary pump, an auto-degasser and a thermostatically controlled column compartment.

“We have had the equipment for ten months now, and it has proved to be a sensitive and reliable upgrade from our previous system,” said John Langford, Head of the Laboratory.

“It is always easy to use, whether we are measuring the gamma emissions of 111indium or the beta emissions of 90yttrium. And the speed and ease of use of LabLogic’s Laura radiochromatography software means that results are available immediately after the end of each run.

“We often correlate our results to ITLC for confirmation, and here we’re finding that the LabLogic radio-TLC scanner provides more detail than the ‘cut and count’ method.

“It makes it easier to locate peaks and discriminate between them and it uses the same Laura software, which is very convenient.”

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
EU ETS benchmark update puts industrial emissions data under sharper scrutiny
Explore more Arrow
Pollution Solutions Online
Next-generation reverse osmosis membranes for more efficient and cost-effective seawater desalination
Explore more Arrow
Petro Online
New test method ASTM D8606 has been officially released
Explore more Arrow
Chromatography Today
Non-invasive flowmeters for real-time monitoring
Explore more Arrow